Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
7.24
+0.21 (2.99%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Relmada Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 759 | 354 | 16 | 125 | 105 | 625 | |
| Market Cap Growth | 7893.59% | 2157.41% | -87.41% | 18.63% | -83.18% | 19.93% | |
| Enterprise Value | 666 | 340 | -38 | 18 | -79 | 537 | |
| Last Close Price | 7.24 | 4.83 | 0.52 | 4.14 | 3.49 | 22.53 | |
| PB Ratio | 6.14 | 4.09 | 0.44 | 1.46 | 0.75 | 3.00 | |
| P/TBV Ratio | 8.78 | 4.09 | 0.44 | 1.46 | 0.75 | 3.00 | |
| Net Debt / Equity Ratio | -1.07 | -1.07 | -1.26 | -1.13 | -1.06 | -1.02 | |
| Net Debt / EBITDA Ratio | - | - | - | - | 0.92 | 1.69 | |
| Net Debt / FCF Ratio | 2.03 | 2.03 | 0.87 | 1.87 | 1.43 | 2.31 | |
| Quick Ratio | 14.46 | 14.46 | 4.36 | 7.90 | 11.94 | 14.08 | |
| Current Ratio | 14.62 | 14.62 | 4.45 | 8.00 | 12.26 | 14.83 | |
| Return on Equity (ROE) | -94.05% | -94.05% | -132.33% | -87.51% | -90.07% | -80.14% | |
| Return on Assets (ROA) | -50.24% | -50.24% | -73.14% | -51.76% | -53.57% | -46.01% | |
| Return on Capital Employed (ROCE) | -64.20% | -64.20% | -236.10% | -121.50% | -114.80% | -60.40% | |
| Earnings Yield | -7.56% | -16.20% | -509.73% | -79.28% | -149.50% | -20.13% | |
| FCF Yield | -6.03% | -12.93% | -329.85% | -41.46% | -98.81% | -14.71% | |
| Buyback Yield / Dilution | -30.89% | -30.89% | -0.21% | -1.59% | -68.80% | -12.56% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.